Previous Article | Next Article ![]()
Infection and Immunity, July 2000, p. 3878-3887, Vol. 68, No. 7
Biophysics Division,1
Electron Microscopy Division,2 and
Human Genetics Department,3 Indian
Institute of Chemical Biology, Jadavpur, Calcutta-700 032, India
Received 30 December 1999/Returned for modification 8 March
2000/Accepted 31 March 2000
Evidence suggests that a repertoire of Vibrio
cholerae genes are differentially expressed in vivo, and
regulation of virulence factors in vivo may follow a different
pathway. Our work was aimed at characterization of in vivo-grown
bacteria and identification of genes that are differentially expressed
following infection by RNA arbitrarily primed (RAP)-PCR fingerprinting.
The ligated rabbit ileal loop model was used. The motility of in
vivo-grown bacteria increased by 350% over that of in vitro-grown
bacteria. Also, the in vivo-grown cells were more resistant to killing
by human serum. By using the RAP-PCR strategy, five differentially expressed transcripts were identified. Two in vitro-induced transcripts encoded polypeptides for the leucine tRNA synthatase and the 50S ribosomal protein, and the three in vivo-induced transcripts encoded the SucA and MurE proteins and a polypeptide of unknown function. MurE
is a protein involved in the peptidoglycan biosynthetic pathway. The
lytic profiles of in vivo- and in vitro-grown cells suspended in
distilled water were compared; the former was found to be slightly less
sensitive to lysis. Ultrathin sections of both cells observed under the
transmission electron microscope revealed that in contrast to the usual
wavy discontinuous membrane structure of the in vitro-grown cells, in
vivo-grown cells had a more rigid, clearly visible double-layered structure. The V. cholerae murE gene was cloned and
sequenced. The sequence contained an open reading frame of 1,488 nucleotides with its own ribosome-binding site. A plasmid containing
the murE gene of V. cholerae was transformed
into V. cholerae 569B, and a transformed strain, 569BME,
containing the plasmid was obtained. Ultrathin sections of 569BME
viewed under a transmission electron microscope revealed a slightly
more rigid cell wall than that of wild-type 569B. When V. cholerae 569B and 569BME cells were injected separately into
ligated rabbit ileal loops, the transformed cells had a preference for
growth in the ileal loops versus laboratory conditions.
Cholera is still a major public
health problem in developing countries as well as in some developed
countries. The causative organism, Vibrio cholerae, is a
gram-negative curved rod, and the life-threatening watery diarrhea is
largely due to the action of the secreted cholera toxin on the
epithelium of the small intestine (8). Several lines of
evidence suggest that a number of V. cholerae genes are
differentially expressed in vivo following infection. The major
virulence genes of V. cholerae O1 biotype Classical under
the coordinate regulation of the transcriptional activator ToxR are
maximally expressed in vitro. In contrast, in the intestinal lumen,
conditions repress the expression of ToxR-controlled virulence factors
(16, 17). Thus, to induce the ToxR-controlled virulence
genes in vivo, V. cholerae may recognize other unknown
external signals in the host environment (20). V. cholerae cells are extremely sensitive to a wide variety of chemicals, particularly hydrophobic compounds and neutral and anionic
detergents, and are much more permeable than Escherichia coli cells (21). This is primarily due to the presence
of exposed phospholipids in the outer leaflet of the outer membrane and
relatively less negative charge on the polysaccharide moiety of
lipopolysaccharide (21). The murein network of V. cholerae is weak, and the cells lyse rapidly in hypotonic medium
as well as in the presence of chelating agents such as Tris and EDTA
(13). Unlike other gram-negative organisms which are
resistant to penicillin, V. cholerae cells are equally
sensitive to penicillin and ampicillin and are much more sensitive to
most of the beta-lactam antibiotics than E. coli
(25).
Recently, using a method based on tnpR operon fusions
encoding a site-specific DNA recombinase, 13 transcriptional units of V. cholerae were identified that were induced during
infection in an infant-mouse model of cholera. Five of these were
predicted to encode polypeptides with diverse functions in metabolism,
biosynthesis, and motility. One encoded a secreted lipase, two seemed
to be antisense to genes involved in motility, and five were predicted to encode polypeptides of unknown function (3). Using
signature-tagged mutagenesis (STM) to conduct a screen for random
insertion mutations that affect colonization in the suckling mouse
model for cholera, five mutants with transposon insertions in toxin
coregulated pilus (TCP) biogenesis genes were isolated. Insertions in
lipopolysaccharide, biotin, and purine biosynthetic genes were also
found to cause colonization defects. Similar results were observed for
mutations in homologs of pta and ptfA, two genes
involved in phosphate transfer. The screen also identified several
novel genes, disruption of which also caused colonization defects in
the mouse model (5). Although two different techniques were
used, none of the in vivo-induced genes was identified twice. Also, it
is well known that the genes in the tcp operon are
responsible for colonization. Only one such gene was isolated,
suggesting that only one third of all the genes responsible could be
identified by the STM method. Moreover, with methods involving
transposon mutagenesis, only genes that are induced in vivo are
identified, but the genes that are repressed may hold some major
information regarding the mechanism of pathogenesis of the organism.
The RNA arbitrarily primed PCR (RAP-PCR) method amplifies subsets of an
mRNA population and separates the resulting cDNAs by denaturing
polyacrylamide gel electrophoresis (PAGE). These two steps resulted in
a collection of DNA molecules that were flanked at their 3' and 5' ends
by the exact sequence (and complement) of the arbitrary primer. These
in turn formed templates for high-stringency PCR amplification.
Although the intensities of different bands within the same fingerprint
vary, the intensity of a band between fingerprints appears to be
proportional to the concentration of its corresponding template or mRNA
(28). A complete pattern of all mRNAs expressed in a
particular cell is possible with a reasonable number of primer pairs
(27). This technique was used to examine differential gene
expression in Salmonella enterica serovar Typhimurium in
response to peroxide treatment (29). Two identical
stress-inducible genes were found in different parts of the genome.
Several differential-display reverse transcriptase-PCR fragments from
Legionella pneumophila induced after a 4-h incubation of
macrophage-like cells were identified (9).
In this study, we attempted a characterization of in vivo-grown
bacteria and identification of genes that are differentially expressed
following infection by RAP-PCR fingerprinting. We identified a set of
genes that are differentially expressed in vivo, one of which is
involved in the peptidoglycan biosynthetic pathway. We cloned this gene
and investigated the potential role of the gene product in the survival
of V. cholerae in vivo.
Bacterial strains and plasmids.
All bacterial strains and
plasmids used in this study are listed in Table
1. The V. cholerae and
E. coli strains were maintained at
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Use of RNA Arbitrarily Primed-PCR Fingerprinting To
Identify Vibrio cholerae Genes Differentially Expressed
in the Host following Infection

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
70°C in Luria-Bertani
(LB) medium containing 20% (vol/vol) glycerol. E. coli
cells were grown in LB medium or M9 medium, and V. cholerae
cells were grown in NB or LB medium. Ampicillin was used at 100 µg/ml
for E. coli and 50 µg/ml for V. cholerae where
appropriate. Plasmids were incorporated into V. cholerae cells by transformation by the method of Panda et al. (18). All cloning experiments were done in pBluescriptKS+. The plasmids were
maintained and amplified in E. coli strains DH5
and XL1 Blue.
TABLE 1.
Bacterial strains and plasmids used in this study
DNA preparation and manipulation. Genomic DNA from V. cholerae 569B was prepared from proteinase K-digested and cetyltrimethylammonium bromide-precipitated cell lysates by standard procedures (2). Plasmid DNA was prepared by the alkaline lysis method (14). Restriction enzymes and DNA-modifying enzymes were purchased from New England BioLabs Inc. (Beverly, Mass.) and used according to the manufacturer's recommendations. For Southern blotting, restriction enzyme-digested chromosomal or plasmid DNA was electrophoresed on 1% agarose gels and blotted on nylon membranes (Nytran; Schleicher & Schuell), using 10× SSC (1× SSC is 0.015 M NaCl plus 0.015 M sodium citrate) (14). The blots were hybridized with DNA fragments labeled with [32P]dCTP (Amersham International, Amersham, U.K.) prepared by using a random-primed labeling kit (New England Biolabs). Subgenomic libraries of V. cholerae DNA were constructed in plasmid pBluescript. Genomic DNA was digested with appropriate restriction enzymes, and the fragments within the size range of interest were excised from agarose gels, purified, ligated with linearized and dephosphorylated plasmid pBluescript, and transformed into E. coli according to standard recombinant DNA techniques (14).
Ligated rabbit ileal loop model. In vivo growth of V. cholerae strains was carried out in the rabbit ileal loop model essentially as described by De and Chatterjee (6). Briefly, rabbits fasted for 48 h were anesthetized, and the small intestine was tied into consecutive 6-cm and 2-cm segments proximally to the mesoappendix. An inoculum of 0.5 µl of V. cholerae strains containing about 5 × 106 CFU was introduced into each 6-cm segment, while one loop was inoculated with saline as a negative control. The intestine was returned to the peritoneal cavity, and the incision was closed. After 16 to 18 h, the animals were sacrificed, and the small intestine was removed. Fluid accumulated in each loop was separately collected and measured. The V. cholerae count in the fluid was measured by plating on thiosulfate-citrate-bile salt-sucrose (TCBS) agar plates. Although no fluid accumulated in the loops inoculated with saline, these loops were also washed and scraped, and bacterial cells in the washings were counted to determine whether the intestine contained any inhabitant. At least two loops in the same animal were inoculated with each bacterial strain, and each strain was tested in at least five individual animals.
Isolation of in vivo-grown bacteria. V. cholerae strains was grown in rabbit ileal loops. After 16 to 18 h, the animals were sacrificed and the small intestine was removed. Fluid accumulated in each loop was collected separately. The fluid was then spun at 1,000 rpm for 5 min to remove the debris. The supernatant was then centrifuged at 5,000 rpm for 10 min to pellet the bacteria.
Swarm plate assay. V. cholerae cells were stabbed into semisolid agar plates containing LB (pH 7.2) solidified with 0.3% Bactoagar (Difco). The plates were incubated at 37°C for 16 to 18 h, and swarm diameters were measured.
Serum assays.
Blood was collected from five healthy
individuals who gave informed consent and was then allowed to clot.
Serum was collected, pooled, and stored at
70°C in aliquots. With
normal human serum and serum heat treated by incubation at 56°C for
30 min to inactivate complement components, serum assays were performed
by a previously described procedure with slight modification
(26). Two different assays were carried out. In one, the
concentration of serum was kept at 35% and 2 × 109
bacterial cells from an exponential-phase or overnight culture or
rabbit intestine were added. The reaction mixture was incubated at
37°C for 3 h. Counts of viable cells were done by taking samples at 0, 1, 2, and 3 h. Percentages for each time point were obtained from surviving viable-cell count versus the initial viable-cell count.
For each culture condition, assays were performed at least four
different times in 35% serum and 35% heat-inactivated serum. In the
other assay, 5 × 109 bacterial cells isolated and
diluted from an exponential-phase or overnight culture or rabbit
intestine were incubated for 2 h at 37°C with serum and
inactivated serum at concentrations of 20, 40, 60, and 80%. Dilutions
of samples were plated onto NA plates and incubated overnight at
37°C, and counts were determined. Percentages for each serum
concentration were obtained from surviving viable-cell count versus the
initial viable-cell count. For each culture condition, assays were
performed at least two different times.
RNA isolation and analysis. For isolation of RNA, cells were grown to the late logarithmic phase in LB (pH 7.2) or overnight in the rabbit intestine. Total RNA was extracted and purified by using guanidium isothiocyanate as described elsewhere (2). RNA samples (15 to 25 µg/well) were electrophoresed in duplicate in 1% agarose-2.1 M formaldehyde-morpholinepropanesulfonic acid gels, and one part was stained with ethidium bromide and visualized with UV light to confirm equal loading of all samples. The other part of the gel was blotted onto nylon membranes by using 20× SSC and hybridized with labeled probes as described elsewhere (2).
DNA sequencing.
Nucleotide sequence was determined with
double-stranded plasmid DNA as the template either by the dideoxy chain
termination method (24) or by cycle sequencing with the
Applied Biosystem Prism dye system (Perkin-Elmer). For manual
sequencing, [
-35S]dATP and the Sequenase 2.0 DNA
sequencing kit (US Biochemical Corp.) were used according to the
manufacturer's instructions.
RAP-PCR fingerprinting of RNA.
RAP was performed essentially
as described by Welsh et al. (28). RNA was first treated
with RNase-free DNase I (Life Technologies). The reaction was stopped
by adding 0.5 M EDTA, and the RNA was extracted with phenol-chloroform
(1:1), ethanol precipitated, washed, and dried. To 10 µl of sample
containing 200 ng of this DNase-treated RNA dissolved in water,
arbitrarily chosen primer was added to a final concentration of 1 µM,
and the mixture was incubated at 68°C for 10 min and then chilled on
ice. cDNA synthesis buffer (10 µl) containing 5 U of Superscript II
RNase H
reverse transcriptase (Life Technologies), 100 mM
Tris-HCl (pH 8.3), 100 mM KCl, 8 mM MgCl2, 20 mM
dithiothreitol, and 2 mM deoxynucleoside triphosphates was added.
First-strand cDNA synthesis was carried out at 37°C for 1 h.
After cDNA synthesis, 10 µl of buffer containing 2 mM Tris-HCl (pH
8.3), 5 mM KCl, 4 mM MgCl2, 1 µM same arbitrarily chosen
primer, 100 µCi of [
-32P]dCTP (3,000 Ci/mmol), and
0.5 U of Taq polymerase was added to the 20-µl cDNA
sample. The thermal cycling parameters were as follows: one
low-stringency cycle; 94°C (5 min), 40°C (5 min), 72°C (5 min);
then 30 high-stringency cycles at 94°C (1 min), 60°C (1 min), and
72°C (2 min). A 10-µl amount of 80% formamide with bromophenol
blue and xylene cyanol dyes was added to 5 µl of each PCR sample. The
samples were heated to 75°C for 15 min and loaded on a standard 5%
polyacrylamide-50% urea sequencing gel prepared in 1×
Tris-borate-EDTA and electrophoresed at 300 V until the xylene cyanol
dye reached the bottom of the gel. The gel was dried under vacuum onto
3MM paper (Whatman). The RAP fingerprint was visualized by
autoradiography using Kodak X-Omat AR film. The primers used in this
study were RSP, AACAGCTATGACCATG; MSP, GTAAAACGACGGCCAGT; BGA1, GTCATCCGTCGATTGCCGGA;
BGC2, GACCATTGCATAACGCTGAC; BGT3,
CCTTAGTGCGTATTATGT; ARB1, CCATGCGCATGCATGAGA;
ARB2, AGAGAGAAACCCACCAGA; and ARB3, CCGCACGCGCACGCAAGG.
Lysis of whole cells. Cells from an exponential-phase or overnight culture or rabbit intestine were harvested by centrifugation (6,000 × g, 10 min) and suspended in distilled water. The extent of lysis was estimated by monitoring the decrease in A585 with respect to the initial value at time zero.
Assay of stability of pAMT150 in 569BME. V. cholerae 569BME was grown overnight in the laboratory and in rabbit ileal loops. The bacteria were harvested, diluted, and plated onto NA and NA plates with ampicillin. Counts of viable cells were made from these plates.
Electron microscopy. For whole cells, cells were fixed with 6% gluteraldehyde (Merck, Darmstadt, Germany), washed in phosphate-buffered saline, stained with uranyl acetate and lead citrate, and examined under a JEOL transmission electron microscope at 60 kV. For thin-section electron microscopy, cells were fixed first with 6% gluteraldehyde in 0.125 M phosphate buffer (pH 7.2) for 14 to 16 h and then with 1% osmium tetroxide (Ted Pella, Inc., Tustin, Calif.) in Kellenberger buffer for 16 to 20 h at room temperature. The fixed cells were washed for 2 h in 0.5% uranyl acetate in the above buffer, dehydrated with ascending concentrations of ethanol, and embedded in spur medium (Poly Sciences, Inc., Warrington, Pa.) at 70°C for 48 h as described previously (13). Sections were cut with a Du Pont diamond knife on an LKB Nova ultramicrotome and stained with uranyl acetate and lead citrate. To visualize the peptidoglycan, a special staining procedure as described elsewhere (11) was used. The sections were floated on 1% periodic acid for 15 min, rinsed with distilled water, and treated with phosphotungstic acid in 10% chromic acid and rinsed for 10 min in distilled water. These were then examined under a JEOL transmission electron microscope at 60 kV.
Protein labeling in maxicells. Plasmid-coded proteins were examined using the maxicell technique (23). Strain CSR603 carrying either pBluescript or pAMT150 was grown (2 × 108 CFU/ml) in M9 medium containing 1% casamino acids. The cell pellet was suspended in the dilution buffer and irradiated with UV light (50 J/m2). The irradiated cells were suspended in fresh medium and incubated at 37°C for 1 h. At the end of this period, 200 µg of D-cycloserine per ml was added, and the incubation was continued for 16 h at 37°C with constant shaking at slow speed. The cells were harvested, washed and suspended in fresh sulfur-depleted medium, and incubated at 37°C for 1 h. The plasmid-coded proteins were then labeled with [35S]methionine (5 µCi/ml) for 1 h at 37°C. The cells were harvested and washed with M9 medium, and the cell lysate was analyzed by sodium dodecyl sulfate (SDS)-15% PAGE followed by fluorography and autoradiography of the dried gel.
Nucleotide sequence accession numbers. The nucleotide and deduced amino acid sequences of the V. cholerae murE gene appear in the EMBL, GenBank, and DDBJ databases under accession no. AF141867. The nucleotide sequences of RAP products appear under accession nos. AF211980, AF211981, AF211982, AF211983, and AF217393.
| |
RESULTS |
|---|
|
|
|---|
Comparison of swarming ability of in vivo- and in vitro-grown
V. cholerae on motility agar plates.
It has recently
been reported that expression of the major virulence factors and
motility are oppositely regulated in V. cholerae (7). Inside the host, the motility of the bacteria is
important for their movement from the point of ingestion to a niche in
the small intestine, where they colonize. The swarming ability of the
in vivo-grown cells in semisolid motility medium containing 0.3% agar
in LB medium (pH 7.2) was compared with that of V. cholerae cells in the exponential phase grown under laboratory conditions. Under
these conditions, the in vitro-grown 569B cells displayed little
motility in the swarm plates. However, the in vivo-grown cells were
significantly more motile, and a 350% increase in swarm diameter was
observed (Fig. 1). This suggests that
regulation of the major virulence factors in vivo and motility may
follow an alternative or slightly modified pathway.
|
Serum sensitivity of in vivo- and in vitro-grown V. cholerae. Once inside the host, the bacteria have to evade the host immune system and then colonize the intestine. It has been reported that mutations in the toxR and tcp genes rendered V. cholerae more sensitive to the vibriocidal activity of antibody and complement (19). It is in this context that the serum sensitivity of in vivo- and in vitro-grown V. cholerae were compared.
Serum samples collected from five healthy individuals were pooled to eliminate interindividual variation. Serum assays were performed with normal human serum and heat-inactivated serum. Two different assays were performed. In one, the concentration of serum was kept at 35% and 2 × 109 bacterial cells isolated and diluted from an exponential-phase or overnight culture or rabbit intestine were added. The reaction mixture was incubated at 37°C for 3 h. Viable-cell counts were determined in duplicate at the end of each hour for 3 h. The results are shown in Fig. 2 as percent viability. As expected for inactivated serum in all three cultures, bacteria increased in number by 150 to 200% in the first hour, with growth reaching a plateau by the third hour of incubation. In presence of normal serum, the in vivo-grown bacteria showed 80% killing in the first hour, reached a plateau, and actually had a slight increase in number after the second hour. In contrast, the laboratory-grown cultures showed more than 90% killing in the first hour and mostly did not survive till the second hour of incubation.
|
|
RAP-PCR fingerprinting of RNA. Bacteria grown under the appropriate condition were immediately frozen on an ice-salt mixture to minimize degradation of mRNA, and total RNA was isolated as described in Materials and Methods. Total RNA isolated from bacteria grown in the laboratory to the exponential phase and bacteria from ligated rabbit ileal loops were subjected to RAP fingerprinting. First-strand cDNA was synthesized using Moloney murine leukemia virus reverse transcriptase with an arbitrarily selected primer. The arbitrarily primed first-strand cDNA is heat denatured and subjected to arbitrarily primed second-strand synthesis using Taq polymerase at low stringency. Products that have the primer sequence at both ends are then PCR amplified at high stringency with simultaneous radiolabeling. Products were separated by denaturing PAGE and visualized by autoradiography. The resulting fingerprint patterns were highly reproducible.
Each fingerprint yielded a pattern of 18 or more clearly visible PCR products (Fig. 4). Pooled RNA samples from at least four different animals were used for each experiment to eliminate rabbit-to-rabbit variations. Fingerprints were generated using eight different primers. For each primer there were 18 or more observable bands in each lane, but only a few differentially amplified cDNA products were observed. The RNA was treated with RNase-free DNase prior to fingerprinting. This eliminated the possibility of genomic DNA contamination. Controls without reverse transcriptase were used with every reaction to rule out possible contamination. Bands specific to in vivo and in vitro RNA were identified, and differentially amplified RAP products were eluted as described in Materials and Methods. At least two separate reactions were performed for each primer for each RNA sample. Only bands that appeared to be differentially expressed in both the reactions were used for further analysis. These were then cloned into the SmaI site of the pBluescript vector, and a partial nucleotide sequence was obtained.
|
-ketogluterate is oxidatively decarboxylated to succinyl coenzyme A and carbon dioxide. pRAP1 induced
in vivo was also predicted to encode a polypeptide that had high
similarity to the MurE protein of E. coli, which catalyzes an intermediate step in the peptidoglycan biosynthetic pathway (Fig.
5). pRAP2 induced in vitro was predicted to be part of a gene encoding
a polypeptide highly homologous to the leucine tRNA synthetase (LeuS)
gene of E. coli (Fig. 5). It catalyzes the binding of
L-leucine to the leucyl-tRNA in the presence of ATP. pRAP4 induced in vitro was also found to be a part of a gene encoding a
polypeptide with a very high similarity to the 50S ribosomal protein of
E. coli (Fig. 5). pRAP3 did not show significant homology to
any sequence deposited in the database.
|
|
Northern blot analysis.
To examine the level of expression of
the differentially expressed transcripts, RNA isolated from in vivo-
and in vitro-grown bacteria was Northern blotted and probed with the
five cDNA fragments isolated by RAP-PCR (Fig.
6). In some cases RNA dot blots were also
used. Specific signals could be detected in each case. Clones pRAP1,
pRAP3, and pRAP5 showed induction in vivo; pRAP2 and pRAP4 were induced
in vitro. The blots were then stripped and reprobed with a V. cholerae rRNA probe as a control (data not shown).
|
Lysis of V. cholerae cells grown in vivo. The structure of the murein network plays a significant role in determining the stability of cell surfaces of bacteria. Several studies have indicated the delicate nature of the murein networks of V. cholerae cells (4, 13, 25). It is a real mystery how these cells survive in the human intestine. Our finding that a peptidoglycan biosynthetic pathway gene is induced in vivo led us to investigate whether in vivo-grown cells are equally susceptible to lysis.
Cells isolated from rabbit ileal loops and cells grown in the laboratory in the stationary or logarithmic phase of growth were suspended in distilled water, and the extent of lysis was compared (Fig. 7). For cells in the stationary phase of growth, the extent of lysis was less than that for cells in the logarithmic phase of growth. In vivo-grown cells were found to be slightly less sensitive to lysis upon suspension in distilled water than those grown in vitro.
|
Ultrastructure of in vivo-grown cells.
The murein network of a
bacterial cell is mainly responsible for its shape and rigidity. On
finding that the murE gene is induced in vivo, we examined
ultrathin sections of V. cholerae cells grown in vivo and in
vitro under the transmission electron microscope. A special periodate
staining procedure for peptidoglycan was used (11). The
laboratory-grown cells had a barely visible discontinuous membrane
structure, whereas in in vivo-grown cells, a typical rigid railroad
pattern was observed (Fig. 8).
|
murE gene of V. cholerae: cloning, nucleotide sequence, and protein sequence. The V. cholerae murE gene was cloned by screening a subgenomic library using the 150-bp cDNA fragment obtained from RAP-PCR fingerprinting as the probe. The sequence of the 2-kb insert in plasmid pAMT200 contained an ORF of 1,488 nucleotides, which is capable of coding for a protein of 495 amino acids whose predicted amino acid sequence is about 56% identical to that of the E. coli MurE protein. A putative ribosome-binding site (GAGA) was centered about 10 nucleotides upstream of the translation initiation site. The synthetase activity of the MurE protein requires ATP hydrolysis, and as previously observed in E. coli (15), a domain characteristic of ATP-binding proteins was found between amino acids 121 and 125. Analysis of the sequence upstream and downstream of murE revealed that the pbpB gene lies immediately upstream and the murF gene lies immediately downstream. This organization is similar to that in E. coli. As our aim was to check the effect of expression of murE in V. cholerae, we amplified a 1,540-bp fragment from the 2-kb region. This contained the putative ORF for murE and nucleotides up to 50 bp upstream of the start codon and thus minimized the possibility of the presence of promoter elements and partial codons of genes downstream of the murE ORF. The PCR product was ligated into the SmaI site of pBluescript and designated pAMT150, and the sequence was verified by cycle sequencing.
The protein(s) encoded by this fragment was examined by using maxicell analysis (23). Plasmid pAMT150 carrying the 1.5-kb DNA fragment was transformed into E. coli strain CSR603. Cells of E. coli CSR603 carrying pAMT150 were irradiated with UV light, labeled with [35S]methionine for 1 h, and the extract of soluble proteins was assayed by SDS-PAGE and autoradiography as described in Materials and Methods. The 1.5-kb DNA fragment was found to encode a protein of 53 kDa (Fig. 9), which is in agreement with the predicted amino acid sequence of 495 amino acids. Plasmid pAMT150 containing the murE gene of V. cholerae was transformed into V. cholerae 569B, and a transformant strain designated 569BME was obtained. 569BME grew well in the presence of ampicillin but tended to lose the plasmid in the absence of the antibiotic. To check if any change in the murein network of this strain has occurred, the lytic profile of 569BME in distilled water was studied as described above. No change in the lytic profile was observed compared with that of the wild-type 569B.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Our results demonstrate that identification of V. cholerae genes that are differentially expressed following infection can be successfully achieved by RAP-PCR fingerprinting. The ligated rabbit ileal loop model was chosen because it provides a close mimicry of the human gut condition. Moreover, it allows comparison of the pathogenicity of more than one strain in the same animal. Lastly, compared to mice models, a greater quantity of bacteria could be isolated from each experiment. The bacteria isolated from the accumulated fluid showed little or no contamination, proving the hypothesis that once given the chance to colonize, V. cholerae outgrows all other intestinal flora.
The swarming ability of the in vivo-grown cells in semisolid motility medium was measured. In vivo-grown bacteria were found to have a swarm diameter 350% larger than that of in vitro-grown bacteria. The swarm plate assay used in this study represents both motility and chemotaxis; a more detailed study would involve measuring the speed using state-of-the-art video microscopy. The in vivo-grown cells were also more resistant to killing by human serum. This is direct evidence that V. cholerae cells adapt for survival in the intestinal milieu. It had been postulated that expression of the major virulence factors and motility are oppositely regulated in V. cholerae (7). It has also been reported that mutations in the toxR and tcp genes rendered V. cholerae more sensitive to the vibriocidal activity of antibody and complement (19). Therefore, our observation that an increase in both motility and resistance to serum sensitivity of in vivo-grown bacteria leads us to the hypothesis that expression of the major virulence genes may follow an alternative or a slightly modified pathway in vivo. A more detailed study involving mutations in candidate genes should be undertaken to identify the genes responsible for these phenotypes.
A recent paper by Camilli and colleagues (12) provides direct evidence that in the infant mouse model, ToxR-regulated genes like ctx and tcp are expressed in vivo with a somewhat different kinetic pattern. We did not get any ToxR- or Tcp-regulated genes because the technique we used actually amplifies and differentiates between mRNA under two or more different conditions. ToxR- and Tcp-regulated genes have a considerable level of expression both in vitro and in vivo. We chose bands that have a considerable and reproducible difference in expression levels in vivo and in vitro, so this may also be the reason that we missed the induced expression of these genes. Also, the results obtained from RAP-PCR analysis are always limited by the total number of primers or primer combinations used.
One of the transcripts found to be induced in vitro was predicted to encode a polypeptide highly homologous to the leucine tRNA synthetase (LeuS) gene of E. coli. The LeuS protein ligates the leucine amino acid to the leucyl-tRNA in presence of ATP. Thus, by regulation of this enzyme in vitro, the regulation of synthesis of a wide variety of proteins requiring this particular aminoacyl tRNA can be achieved. The other in vitro-induced transcript was found to be a part of a gene encoding a polypeptide with a very high similarity to the 50S ribosomal protein of E. coli. The 50S ribosomal protein is required for protein synthesis. In fact, we identified two genes that are repressed in vivo, and both relate to protein synthesis. This is not surprising, as in the stressful environment within the host, very few proteins are allowed to be synthesized at a high rate. This helps the pathogen make proper use of the limited resources in vivo and synthesize proteins that are essential for virulence and survival within the host.
Of the three in vivo-induced cDNA fragments, one corresponded to the
already identified iviII gene of V. cholerae.
Interestingly, iviII is actually an in vivo-induced
transcript in V. cholerae, as reported by Camilli and
Mekalanos (3). At the protein level, it showed homology to
the E. coli SucA protein. SucA is part of a multisubunit
enzyme that catalyzes a step in the tricarboxylic acid cycle in which
-ketogluterate is oxidatively decarboxylated to succinyl coenzyme A
and carbon dioxide. The fact that a particular in vivo-induced gene was
identified by two different techniques is an indirect proof of the
reliability and accuracy of both methods. The second in vivo-induced
transcript was predicted to encode a polypeptide that had high
similarity to the MurE protein of E. coli, which catalyzes
an intermediate step in the peptidoglycan biosynthetic pathway. The
third cDNA fragment did not show homology to any sequence in the database.
The fact that murE, a gene involved in the peptidoglycan biosynthetic pathway, is induced in vivo did not come as a surprise to us. In fact, several studies have indicated the fragile nature of the murein networks of V. cholerae cells (4, 13, 25). In E. coli, the peptidoglycan network is thin but "more than a monolayer" (10). The peptidoglycan content of V. cholerae 569B is about 0.5% of the cellular dry weight, a percentage much lower than that in other gram-negative bacteria (13). It is really intriguing how these cells survive in the human intestine. When the lytic profiles of in vivo- and in vitro-grown cells suspended in distilled water were compared, the former was found to be slightly less sensitive to lysis. Ultrathin sections of both cells observed under the transmission electron microscope revealed that in contrast to the usual wavy discontinuous membrane structure of the in vitro-grown cells, in vivo-grown cells had a more rigid, clearly visible double-layered structure. These experiments were repeated several times, each time with a different animal, and were reproducible. Moreover, the periodate method of staining (11) reflects peptidoglycan only. The increased level of peptidoglycan could be due to differences in osmolarity, especially since it has been reported earlier that the level of peptidoglycan in V. cholerae grown in 1% NaCl is higher than when grown without NaCl (13). The murein network of a cell is responsible for its shape and rigidity, protecting the cell against osmotic shock. This observation indicates that V. cholerae cells modulate their peptidoglycan content in vivo to help them survive in the intestinal environment.
Using the murE cDNA fragment as probe, the V. cholerae murE gene was cloned and the cloned gene was confirmed by comparison of its nucleotide sequence with the database. The sequence contained an ORF of 1,488 nucleotides with its own ribosome-binding site. The analysis of sequences upstream and downstream of the murE gene revealed that the organization of the locus in V. cholerae is similar to that in E. coli, with the pbpB gene immediately upstream and the murF gene immediately downstream of the predicted ORF. Maxicell analysis revealed a 53-kDa protein, in agreement with the predicted amino acid sequence of 495 amino acids.
The obvious question arose of whether the change in cell surface characteristics of V. cholerae in vivo is due to the induction of murE alone or a multigenic process. A plasmid containing the murE gene of V. cholerae was transformed into V. cholerae 569B, and transformed strain 569BME containing the plasmid was obtained. The lytic profile of V. cholerae 569BME suspended in distilled water did not show any significant difference compared with the wild-type strain. Ultrastructural analysis revealed a slightly more rigid and continuous membrane structure than in the wild-type 569B. This indicates that although a slightly greater rigidity in the cell surface may have been imparted by expression of the cloned murE gene, to achieve the major changes in phenotypes observed in in vivo-grown cells, a multigene process is involved. To find a more complete answer to the question, the other genes related to the cell surface and peptidoglycan structure of V. cholerae need to be identified and analyzed.
Recent reports showed that the intracellular residence of S. enterica serovar Typhimurium within epithelial cells is accompanied by significant changes in the bacterial cell wall (22). It has also been reported that environmental non-O1 vibrios are more resistant to various lytic agents than their O1 counterparts and also that they possess more peptidoglycan (4). Our findings suggest that pathogenic strains of V. cholerae may in fact modulate their peptidoglycan content in response to environmental stimuli, as within the host. However, not all the phenotypic differences observed persist after subculture. Using promoter reporter constructs, the factors that stimulate the induction of these can be identified, and the data obtained may lead to the discovery of new therapeutic and prophylactic agents against this pathogen.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by research grant SP/SO/D-56/96 from the Department of Science and Technology, Govt. of India. A.C. is grateful to the Council of Scientific and Industrial Research for a research fellowship.
We thank S. N. Dey, I. Guhathakurta, and R. Banerjee for excellent technical support.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Scientist E1 & Head, Biophysics Division, Indian Institute of Chemical Biology, 4, Raja S. C. Mullick Road, Calcutta-700 032, India. Phone: 91-33-473-0350. Fax: 91-33-473-5197 or 91-33-473-0284. E-mail: keya{at}cal2.vsnl.net.in.
Present address: Department of Biochemistry and Molecular Biology
(MC536), College of Medicine, Chicago, IL 60612-7334.
Editor: A. D. O'Brien
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Altschul, S. F.,
T. L. Madden,
A. A. Schäffer,
J. Zhang,
Z. Zhang,
W. Miller, and D. J. Lipman.
1997.
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
Nucleic Acids Res.
25:3389-3402 |
| 2. | Ausubel, F., M. R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1989. Current protocols in molecular biology. John Wiley & Sons, New York, N.Y. |
| 3. | Camilli, A., and J. J. Mekalanos. 1995. Use of recombinase gene fusions to identify Vibrio cholerae genes induced during infection. Mol. Microbiol. 18:671-683[CrossRef][Medline]. |
| 4. |
Chaudhuri, K.,
R. K. Bhadra, and J. Das.
1992.
Cell surface characteristics of environmental and clinical isolates of Vibrio cholerae non-O1.
Appl. Environ. Microbiol.
58:3567-3573 |
| 5. | Chiang, S. L., and J. J. Mekalanos. 1998. Use of signature-tagged transposon mutagenesis to identify Vibrio cholerae genes critical for colonization. Mol. Microbiol. 27:797-805[CrossRef][Medline]. |
| 6. | De, S. N., and S. N. Chatterjee. 1953. An experimental study of the mechanisms of action of Vibrio cholerae on the intestinal mucus membrane. J. Pathol. Bacteriol. 46:559-562[CrossRef]. |
| 7. | Gardel, C., and J. J. Mekalanos. 1996. Alterations in Vibrio cholerae motility phenotypes correlate with changes in virulence factor expression. Infect. Immun. 64:2246-2255[Abstract]. |
| 8. | Kaper, J. B., J. G. Morris, Jr., and M. N. Levine. 1995. Cholera. Clin. Microbiol. Rev. 8:48-86[Abstract]. |
| 9. | Kwaik, Y. A., and L. L. Pederson. 1996. The use of differential display-PCR to isolate and characterize a Legionella pneumophila locus induced during the intracellular infection of macrophages. Mol. Microbiol. 21:543-556[CrossRef][Medline]. |
| 10. |
Labischinski, H.,
E. W. Goodell,
A. Goodell, and M. L. Hochberg.
1991.
Direct proof of a "more than single layered" peptidoglycan architechtiure of Escherichia coli W7: a neutron small-angle-scattering study.
J. Bacteriol.
173:751-756 |
| 11. |
Leduc, M.,
C. Frehel, and J. van Heijenoort.
1985.
Correlation between degradation and ultrastructure of peptidoglycan during autolysis of Escherichia coli.
J. Bacteriol.
161:627-635 |
| 12. | Lee, S. M., D. L. Hava, M. K. Waldor, and A. Camilli. 1999. Regulation and temporal expression patterns of Vibrio cholerae virulence genes during infection. Cell 99:625-634[CrossRef][Medline]. |
| 13. |
Lohia, A.,
S. Majumdar,
A. N. Chatterjee, and J. Das.
1985.
Effect of changes in the osmolarity of the growth medium of Vibrio cholerae cells.
J. Bacteriol.
163:1158-1166 |
| 14. | Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 15. | Michaud, C., C. Parquet, B. Flouret, D. Blanot, and J. Heijenoort. 1990. Revised interpretation of the sequence containing the murE gene encoding UDP-N-acetylmuramyl-tripeptide synthetase of Escherichia coli. Biochem. J. 269:277-280[Medline]. |
| 16. |
Miller, V. L., and J. J. Mekalanos.
1984.
Synthesis of cholera toxin is positively regulated at the transcriptional level by toxR.
Proc. Natl. Acad. Sci. USA
81:3471-3475 |
| 17. |
Miller, V. L., and J. J. Mekalanos.
1988.
A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR.
J. Bacteriol.
170:2575-2583 |
| 17a. | Mukherjee, S. 1978. Principles and practice of typing V. cholerae. Methods Microbiol. 12:483-497. |
| 18. | Panda, D. K., U. Dasgupta, and J. Das. 1991. Transformation of Vibrio cholerae by plasmid DNA. Gene 105:107-111[CrossRef][Medline]. |
| 19. |
Parsot, C.,
E. Taxman, and J. J. Mekalanos.
1991.
ToxR regulates the production of lipoproteins and expression of serum resistance in Vibrio cholerae.
Proc. Natl. Acad. Sci. USA
88:1641-1645 |
| 20. |
Parsot, C., and J. J. Mekalanos.
1990.
Expression of ToxR, the transcriptional activator of virulence factors of Vibrio cholerae, is modulated by the heat shock response.
Proc. Natl. Acad. Sci. USA
87:9898-9902 |
| 21. |
Paul, S.,
K. Chaudhuri,
A. N. Chatterjee, and J. Das.
1992.
Presence of exposed phospholipids in the outer membrane of Vibrio cholerae.
J. Gen. Microbiol.
138:755-761 |
| 22. | Quintela, J. C., M. A. de Pedro, P. Zollner, G. Allmaier, and F. Garcia-del-Portillo. 1997. Peptidoglycan structure of Salmonella typhimurium growing within cultured mammalian cells. Mol. Microbiol. 23:693-704[CrossRef][Medline]. |
| 23. |
Sancar, A.,
A. A. Hach, and W. D. Rupp.
1979.
Simple method for identification of plasmid-coded proteins.
J. Bacteriol.
137:692-693 |
| 24. |
Sanger, F.,
S. Nicklen, and A. R. Coulsen.
1977.
DNA sequencing with chain termination inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467 |
| 25. |
Sengupta, T. K.,
K. Chaudhuri,
S. Majumdar,
A. Lohia,
A. N. Chatterjee, and J. Das.
1992.
Interaction of Vibrio cholerae cells with -lactam antibiotics: emergence of resistant cells at a high frequency.
Antimicrob. Agents Chemother.
36:788-795 |
| 26. | Taylor, P. W. 1985. Measurement of the bactericidal activity of the serum, p. 445-457. In M. Sussman (ed.), The virulence of Escherichia coli. Academic Press Ltd., London, England. |
| 27. | Wang, J., S. Lory, R. Ramphal, and S. Jin. 1996. Isolation and characterization of Pseudomonas aeruginosa genes inducible by respiratory mucus derived from cystic fibrosis patients. Mol. Microbiol. 22:1005-1012[CrossRef][Medline]. |
| 28. |
Welsh, J., and M. McClelland.
1990.
Fingerprinting genomes using PCR with arbitrary primers.
Nucleic Acids Res.
21:4272-4280 |
| 29. |
Wong, K. K., and M. McClelland.
1994.
Stress-inducible gene of Salmonella typhimurium identified by arbitrarily primed PCR of RNA.
Proc. Natl. Acad. Sci. USA
91:639-643 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»